Form 10-Q Venus Concept Inc. For: Jun 30
http://archive.fast-edgar.com/20220812/AVZ2M22CZM22P2Z2222O2MZZS6GDQ6T86242
Filed on: August 12, 2022
Form 8-K LEAP THERAPEUTICS, INC. For: Aug 11
0001509745
false
0001509745
2022-08-11
2022-08-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(D)
of the... (continue reading...)
Form 8-K Venus Concept Inc. For: Aug 12
false000140926900014092692022-08-122022-08-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2022
... (continue reading...)
Form 6-K PEARSON PLC For: Aug 12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August
2022
PEARSON plc
(Exact
name of registrant as specified in its charter)
N/A
(Translation
of registrant's name into English)
80 Strand
London, England WC2R 0RL
44-20-7010-2000
(Address
of... (continue reading...)
Form 8-K Chemomab Therapeutics For: Aug 12
false00-00000000001534248NASDAQNASDAQ00015342482022-08-122022-08-120001534248cmmb:AmericanDepositarySharesEachRepresentingTwenty20OrdinarySharesNoParValuePerShareMember2022-08-122022-08-120001534248cmmb:OrdinarySharesNoParValuePerShareMember2022-08-122022-08-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
More SEC Filings
View Older Stories-
Form 10-Q ATHERSYS, INC / NEW For: Jun 30
-
Form 8-K Applied Therapeutics For: Aug 12
-
Form 8-A12B RAPID MICRO BIOSYSTEMS,
-
Form 8-K Humacyte, Inc. For: Aug 12
-
Form 8-K Instil Bio, Inc. For: Aug 12
-
Form D/A Rokos Global Macro Fund
-
Form 8-K Real Good Food Company, For: Aug 12
-
Form 6-K Americas Gold & Silver For: Aug 12
-
Form 6-K Orla Mining Ltd. For: Aug 12
-
Form 8-K Ampio Pharmaceuticals, For: Aug 10
-
Form 6-K MAVERIX METALS INC. For: Aug 12
-
Form 10-Q ProMIS Neurosciences For: Jun 30
-
Form 10-K NEWS CORP For: Jun 30
-
Form 13F-HR DSM CAPITAL PARTNERS For: Jun 30
-
Form D/A Rokos Global Macro Fund
-
Form 8-K PLx Pharma Inc. For: Aug 12
-
Form 4 VOXX International Corp For: Aug 11 Filed by: Kahli Beat
-
Form 6-K NXT Energy Solutions For: Aug 11
-
Form 6-K Americas Gold & Silver For: Aug 12
-
Form D/A Rokos Global Macro Fund
-
Form 6-K PRUDENTIAL PLC For: Aug 12
-
Form 6-K MIZUHO FINANCIAL GROUP For: Aug 12
-
Form 13F-HR Eisler Capital (UK) Ltd. For: Jun 30
-
Form 6-K Brookfield Business Part For: Aug 12
-
Form 6-K Brookfield Business Corp For: Aug 12
-
Form 13F-HR China Universal Asset For: Jun 30
-
Form 10-Q Unity Biotechnology, For: Jun 30
-
Form 6-K ASLAN Pharmaceuticals For: Jun 30
-
Form 13F-HR Asia Research & Capital For: Jun 30
-
Form 10-Q LEAP THERAPEUTICS, INC. For: Jun 30
-
Form 6-K Sands China Ltd. For: Aug 12
-
Form 6-K NatWest Group plc For: Aug 12
-
Form 6-K MITSUBISHI UFJ FINANCIAL For: Aug 12
-
Form ABS-15G NOMURA ASSET ACCEPTANCE For: Jun 30
-
Form 6-K RYANAIR HOLDINGS PLC For: Aug 12
-
Form ABS-15G Nomura Home Equity Loan, For: Jun 30
-
Form SC 13D/A Wave Life Sciences Ltd. Filed by: Shin Nippon Biomedical Laboratories, Ltd.
-
Form 4 TELA Bio, Inc. For: Aug 10 Filed by: Opaleye Management Inc.
-
Form 424B5 Broadstone Net Lease,
-
Form 13F-HR SCEP Management Ltd For: Jun 30
-
Form 13F-NT TMB Asset Management For: Jun 30
-
Form 13F-HR CANADA PENSION PLAN INVE For: Jun 30
-
Form 13F-NT Eastspring Securities For: Jun 30
-
Form 6-K ASTRAZENECA PLC For: Aug 12
-
Form 6-K PETROCHINA CO LTD For: Aug 12
-
Form 8-K Spectrum Brands Holdings For: Aug 12
-
Form 6-K MITSUBISHI UFJ FINANCIAL For: Aug 12
-
Form 13F-NT EASTSPRING INVESTMENTS For: Jun 30
-
Form 8-K FLOWERS FOODS INC For: Aug 11
-
Form 10-Q TRANS GLOBAL GROUP, INC. For: Jun 30
